Valerie Ray
Chief Operating Officer at PhotonPharma, Inc.
Profile
Valerie Ray is currently the Vice President-Internal Operations at PhotonPharma, Inc. Prior to this, she worked as the Executive Director-Manufacturing at LightDeck Diagnostics, Inc. and as the Vice President-Operations at Encision, Inc. from 2014 to 2017.
She also worked as a Program Manager at Baxter Corporation Englewood and as a Product Manager at Terumo BCT, Inc. Dr. Ray holds a graduate degree from the University of Colorado Boulder, an MBA from Daniels College of Business, and an undergraduate degree from the University of Colorado Denver.
Valerie Ray active positions
Companies | Position | Start |
---|---|---|
PhotonPharma, Inc.
PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is a company that is developing a personalized therapeutic cancer vaccine called Innocell. The company is based in Fort Collins, CO, at the Research Innovation Center of Colorado State University. The vaccine is designed using autologous tumor tissue and a photochemical inactivation platform that uses riboflavin and UV light to render tumor cells incapable of replication while still being able to metabolize, express proteins, present antigen, and stimulate immune recognition and response mechanisms. The company has demonstrated the ability of this technology to prevent metastatic tumor formation, reduce the growth of tumors, and stimulate cellular immune response pathways in preclinical development animal models. The company was founded in 2018 by Raymond Goodrich, and the CEO is Alan S. Rudolph. | Chief Operating Officer | - |
Former positions of Valerie Ray
Companies | Position | End |
---|---|---|
ENCISION INC. | Chief Operating Officer | 2017-03-14 |
Terumo BCT, Inc.
Terumo BCT, Inc. Medical DistributorsDistribution Services Terumo BCT, Inc. develops and provides blood component and cellular technologies with the combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company offers products in the areas of apheresis collections, therapeutic apheresis, cell therapy systems, and whole blood processing and pathogen reduction technologies. Its products include information systems, data collection systems, apheresis systems, pathogen reduction technology systems, whole blood processing systems, orbisac systems, cell expansion systems, IIB sterile tubing welders, blood bags, and blood bag systems. The company was founded by Robert Collins and Randall Bellows in 1964 and is headquartered in Lakewood, CO. | Corporate Officer/Principal | - |
LightDeck Diagnostics, Inc.
LightDeck Diagnostics, Inc. BiotechnologyHealth Technology Lightdeck Diagnostics engages in the development of clinical diagnostics and sample testing products. It offers the LightDeck platform, which consists of portable fluorescence analyzer and disposable, multiplex test cartridges. Its products are used in the medical, veterinary, environmental, food, agricultural, and military market segments. The company was founded by Christopher J. Myatt, Michael J. Lockhead, and Sarah C. Hatcher in 2009 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - |
Baxter Corporation Englewood
Baxter Corporation Englewood Electronic Equipment/InstrumentsElectronic Technology Baxter Corporation Englewood engages in the provision of medical device solutions. The company was founded by Ronald Baxa and Brian E. Baldwin in 1975 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Training of Valerie Ray
University of Colorado Denver | Undergraduate Degree |
University of Colorado Boulder | Graduate Degree |
Daniels College of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ENCISION INC. | Health Technology |
Private companies | 4 |
---|---|
Baxter Corporation Englewood
Baxter Corporation Englewood Electronic Equipment/InstrumentsElectronic Technology Baxter Corporation Englewood engages in the provision of medical device solutions. The company was founded by Ronald Baxa and Brian E. Baldwin in 1975 and is headquartered in Deerfield, IL. | Electronic Technology |
LightDeck Diagnostics, Inc.
LightDeck Diagnostics, Inc. BiotechnologyHealth Technology Lightdeck Diagnostics engages in the development of clinical diagnostics and sample testing products. It offers the LightDeck platform, which consists of portable fluorescence analyzer and disposable, multiplex test cartridges. Its products are used in the medical, veterinary, environmental, food, agricultural, and military market segments. The company was founded by Christopher J. Myatt, Michael J. Lockhead, and Sarah C. Hatcher in 2009 and is headquartered in Boulder, CO. | Health Technology |
Terumo BCT, Inc.
Terumo BCT, Inc. Medical DistributorsDistribution Services Terumo BCT, Inc. develops and provides blood component and cellular technologies with the combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company offers products in the areas of apheresis collections, therapeutic apheresis, cell therapy systems, and whole blood processing and pathogen reduction technologies. Its products include information systems, data collection systems, apheresis systems, pathogen reduction technology systems, whole blood processing systems, orbisac systems, cell expansion systems, IIB sterile tubing welders, blood bags, and blood bag systems. The company was founded by Robert Collins and Randall Bellows in 1964 and is headquartered in Lakewood, CO. | Distribution Services |
PhotonPharma, Inc.
PhotonPharma, Inc. BiotechnologyHealth Technology PhotonPharma, Inc. is a company that is developing a personalized therapeutic cancer vaccine called Innocell. The company is based in Fort Collins, CO, at the Research Innovation Center of Colorado State University. The vaccine is designed using autologous tumor tissue and a photochemical inactivation platform that uses riboflavin and UV light to render tumor cells incapable of replication while still being able to metabolize, express proteins, present antigen, and stimulate immune recognition and response mechanisms. The company has demonstrated the ability of this technology to prevent metastatic tumor formation, reduce the growth of tumors, and stimulate cellular immune response pathways in preclinical development animal models. The company was founded in 2018 by Raymond Goodrich, and the CEO is Alan S. Rudolph. | Health Technology |
- Stock Market
- Insiders
- Valerie Ray